scholarly article | Q13442814 |
P356 | DOI | 10.4269/AJTMH.2006.75.32 |
P8608 | Fatcat ID | release_x7n5jn26xzg57o4y252fzzpjte |
P698 | PubMed publication ID | 16931813 |
P50 | author | Amanda Ross | Q42816827 |
P2093 | author name string | Gerry Killeen | |
Thomas Smith | |||
P433 | issue | 2 Suppl | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | infectivity | Q1662346 |
Plasmodium falciparum | Q311383 | ||
P304 | page(s) | 32-37 | |
P577 | publication date | 2006-08-01 | |
P1433 | published in | American Journal of Tropical Medicine and Hygiene | Q15766943 |
P1476 | title | Relationships between host infectivity to mosquitoes and asexual parasite density in Plasmodium falciparum | |
P478 | volume | 75 |
Q41992262 | A Novel Gametocyte Biomarker for Superior Molecular Detection of the Plasmodium falciparum Infectious Reservoirs |
Q56342178 | Agent-based models of malaria transmission: a systematic review |
Q36353796 | Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission |
Q38935681 | Assessing the impact of next-generation rapid diagnostic tests on Plasmodium falciparum malaria elimination strategies |
Q37530299 | Challenges of assessing the clinical efficacy of asexual blood-stage Plasmodium falciparum malaria vaccines |
Q26315556 | Correlations between household occupancy and malaria vector biting risk in rural Tanzanian villages: implications for high-resolution spatial targeting of control interventions |
Q38917744 | Determinants of Malaria Transmission at the Population Level |
Q28477679 | Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and children |
Q34659997 | Development of a new version of the Liverpool Malaria Model. I. Refining the parameter settings and mathematical formulation of basic processes based on a literature review |
Q36127097 | Distribution of malaria exposure in endemic countries in Africa considering country levels of effective treatment |
Q33587420 | Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children |
Q34281705 | Emergence and prevalence of human vector-borne diseases in sink vector populations. |
Q28732752 | Ensemble modeling of the likely public health impact of a pre-erythrocytic malaria vaccine |
Q36478707 | Estimation of heterogeneity in malaria transmission by stochastic modelling of apparent deviations from mass action kinetics |
Q33616091 | Falciparum malaria as an emerging cause of fever in adults living in Gabon, Central Africa |
Q61445295 | From high to low malaria transmission in Zanzibar-challenges and opportunities to achieve elimination |
Q36667585 | Heterogeneous distribution of Plasmodium falciparum drug resistance haplotypes in subsets of the host population |
Q39932709 | How selection forces dictate the variant surface antigens used by malaria parasites |
Q35022983 | Human-to-mosquito transmission efficiency increases as malaria is controlled |
Q28543825 | Impact of Schistosoma mansoni on malaria transmission in Sub-Saharan Africa |
Q44787755 | Individual and household characteristics of persons with Plasmodium falciparum malaria in sites with varying endemicities in Kinshasa Province, Democratic Republic of the Congo |
Q36087367 | Interdependence of domestic malaria prevention measures and mosquito-human interactions in urban Dar es Salaam, Tanzania |
Q33926064 | Interpreting malaria age-prevalence and incidence curves: a simulation study of the effects of different types of heterogeneity |
Q37125879 | Is a reproduction number of one a threshold for Plasmodium falciparum malaria elimination? |
Q37113126 | Linking environmental variability to village-scale malaria transmission using a simple immunity model |
Q36568243 | Malaria parasite diversity and transmission intensity affect development of parasitological immunity in a mathematical model |
Q36717792 | Markets, voucher subsidies and free nets combine to achieve high bed net coverage in rural Tanzania |
Q52321413 | Medical and entomological malarial interventions, a comparison and synergy of two control measures using a Ross/Macdonald model variant and openmalaria simulation. |
Q36881018 | Modeling the human infectious reservoir for malaria control: does heterogeneity matter? |
Q34787802 | Modeling the public health impact of malaria vaccines for developers and policymakers |
Q37024361 | Modelling heterogeneity and the impact of chemotherapy and vaccination against human hookworm |
Q36531354 | Modelling the cost-effectiveness of mass screening and treatment for reducing Plasmodium falciparum malaria burden |
Q33752125 | Nonlinear mixed effects modeling of gametocyte carriage in patients with uncomplicated malaria. |
Q34496220 | Optimal seasonal timing of oral azithromycin for malaria |
Q34427744 | P. falciparum infection durations and infectiousness are shaped by antigenic variation and innate and adaptive host immunity in a mathematical model |
Q36994045 | Plasmodium development in the mosquito: biology bottlenecks and opportunities for mathematical modeling |
Q34984903 | Population-level effects of clinical immunity to malaria |
Q33996191 | Potential benefits, limitations and target product-profiles of odor-baited mosquito traps for malaria control in Africa |
Q36864852 | Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection |
Q33289778 | Preventing childhood malaria in Africa by protecting adults from mosquitoes with insecticide-treated nets |
Q28475084 | Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies |
Q33794662 | Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study |
Q28729000 | Simplified models of vector control impact upon malaria transmission by zoophagic mosquitoes |
Q57614293 | Site-occupancy modelling as a novel framework for assessing test sensitivity and estimating wildlife disease prevalence from imperfect diagnostic tests |
Q64065678 | Synergy and timing: a concurrent mass medical campaign predicted to augment indoor residual spraying for malaria |
Q35428591 | Target product profile choices for intra-domiciliary malaria vector control pesticide products: repel or kill? |
Q55420162 | The decline of malaria in Vietnam, 1991-2014. |
Q34429326 | The dynamics of natural Plasmodium falciparum infections |
Q27304630 | The time-course of protection of the RTS,S vaccine against malaria infections and clinical disease |
Q33507997 | The use of insecticide treated nets by age: implications for universal coverage in Africa |
Q34806993 | Towards a comprehensive simulation model of malaria epidemiology and control. |
Q28078982 | Transmission-blocking strategies: the roadmap from laboratory bench to the community |
Q33368617 | What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines |
Q97636638 | Why lockdown? Why national unity? Why global solidarity? Simplified arithmetic tools for decision-makers, health professionals, journalists and the general public to explore containment options for the 2019 novel coronavirus |
Q53792928 | Within-host competition and drug resistance in the human malaria parasite Plasmodium falciparum. |
Search more.